Abstract
Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
- Received September 4, 2014.
- Accepted November 10, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Editorial – Human tissue models in cancer research: looking beyond the mouse
Samuel Jackson and Gareth Thomas discuss the limitations of patient-derived xenograft mouse models and highlight initiatives to maximise the use of human tissue in cancer research, with the goal of improving translation and reducing animal experimentation.
DMM Conference Travel Grants
Is there a conference or meeting you'd love to attend but your budget doesn't stretch that far? Apply for a DMM Conference Travel Grant - our next deadline is 31 August. Find out more here.
First person – a new series of interviews
We are pleased to announce a new series of interviews with the first authors of articles published in DMM, giving authors the opportunity to promote themselves alongside their papers and share their thoughts on being an early career researcher. We launch the series with two interviews; the first is with Josefin Fernius, first author on a Research article investigating the subcellular effects of human neurodegenerative disease proteins using Drosophila leg neurons. The second is with Aaro Salminen and Lillian Garrett, co-first authors on a Research article revealing how Meis1 affects motor phenotypes and the sensorimotor system in mice.
Call for papers: Cancer metabolism special collection
DMM invites you to submit original research for a special collection focused on the dysregulation of metabolic pathways in cancer initiation, progression and resistance to treatment. This ongoing collection will be launched with a special issue scheduled for publication in spring 2018, with the special issue guest edited by Almut Schulze (University of Würzberg, Germany) and Mariia Yuneva (Crick Institute, London, UK).
Find out more here.
Travelling Fellowship - Coming in from the cold
Multidisciplinary researcher Blanca Figuerola used a Travelling Fellowship from DMM to visit Dr Angelo Fontan’s lab at the ICB in Italy. There, she learned a number of chemical techniques to help her study the chemical ecology of Antarctic bryozoans on a research campaign to Antarctica. Read her story here.
Where could your research take you? The deadline for the current round of applications for a DMM Travelling Fellowship is 31 August. Find out more here.